{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:14:03Z","timestamp":1721826843836},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1971,9,1]],"date-time":"1971-09-01T00:00:00Z","timestamp":52531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacologia"],"published-print":{"date-parts":[[1971,9]]},"DOI":"10.1007\/bf00401786","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T08:05:35Z","timestamp":1099987535000},"page":"234-249","source":"Crossref","is-referenced-by-count":9,"title":["Studies on the central effects of bulbocapnine"],"prefix":"10.1007","volume":"22","author":[{"given":"A.","family":"Loizzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Scotti","family":"de Carolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. G.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"168","volume-title":"Psychotropic Drugs","author":"G. Alema'","year":"1957","unstructured":"Alema', G., Sergio, C.: On the influence of some pharmacological substances upon the experimental catatonia produced by bulbocapnine, reserpine and chlorpromazine in rats. In: Psychotropic Drugs, pp. 168?170. S. Garattini and V. Ghetti, edit. Amsterdam: Elsevier 1957."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(70)90006-3","volume":"11","author":"N. E. And\u00e8n","year":"1970","unstructured":"And\u00e8n, N. E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol. 11, 303?314 (1970).","journal-title":"Europ. J. Pharmacol."},{"key":"CR3","first-page":"1257","volume":"18","author":"J. R. Boissier","year":"1963","unstructured":"Boissier, J. R., Simon, P.: Un test simple pour l'\u00e9tude quantitative de la catatonie provoqu\u00e9e chez le rat par les neuroleptiques. Application \u00e0 l'\u00e9tude des anticatatoniques. Th\u00e9rapie 18, 1257?1277 (1963).","journal-title":"Th\u00e9rapie"},{"key":"CR4","first-page":"1247","volume":"45","author":"P. Borenstein","year":"1969","unstructured":"Borenstein, P., Geki\u00e8re, F., Aleonard, P., Gruet-Masson, J., All\u00e8gre, G.: Etude neurophysiologique de l'action psychomotrice d'une drogue: a propos de la catatonie bulbocapnique. Sem. H\u00f4p. Paris 45, 1247?1257 (1969).","journal-title":"Sem. H\u00f4p. Paris"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/0006-2952(65)90020-1","volume":"14","author":"E. A. Carlini","year":"1965","unstructured":"Carlini, E. A., Sampaio, M. R. P., Santos, M., Carlini, G. R. S.: Potentiation of histamine and inhibition of diamine-oxidase by catatonic drugs. Biochem. Pharmacol. 14, 1657?1663 (1965).","journal-title":"Biochem. Pharmacol."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1748-1716.1962.tb02331.x","volume":"54","author":"A. Carlsson","year":"1962","unstructured":"Carlsson, A., Lindqvist, M.: In vivo decarboxylation of ?-methyl-DOPA and ?-methylmetatyrosine. Acta physiol. scand. 54, 87?94 (1962).","journal-title":"Acta physiol. scand."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-2952(62)90075-8","volume":"11","author":"J. E. Chapman","year":"1962","unstructured":"Chapman, J. E., Walaszek, E. J.: Inhibition of diamine oxidase by bulbocapnine. Biochem. Pharmacol. 11, 205?210 (1962).","journal-title":"Biochem. Pharmacol."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.166.3907.899","volume":"166","author":"J. T. Coyle","year":"1969","unstructured":"Coyle, J. T., Snyder, S. H.: Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science 166, 899?901 (1969).","journal-title":"Science"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0024-3205(66)90134-2","volume":"5","author":"J. Crossland","year":"1966","unstructured":"Crossland, J., Woodruff, G. N., Woodruff, J. H.: The histamine content of brain during bulbocapnine-induced catalepsy. Life Sci. 5, 193?197 (1966).","journal-title":"Life Sci."},{"key":"CR10","first-page":"141","volume":"15","author":"A. M. Ernst","year":"1969","unstructured":"Ernst, A. M.: The role of biogenic amines in the extrapyramidal system. Acta physiol. pharmacol. neerl. 15, 141?154 (1969).","journal-title":"Acta physiol. pharmacol. neerl."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0028-3908(71)90007-4","volume":"10","author":"V. Florio","year":"1971","unstructured":"Florio, V., Longo, V. G.: Neuroleptic drugs and the central dopaminergic system. Antagonism between L-DOPA and some butyrophenones on the EEG and motor effects due to stimulation of the mesencephalon in the rabbit. Neuropharmacology 10, 45?54 (1971).","journal-title":"Neuropharmacology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.169.3941.203","volume":"169","author":"R. P. Grelak","year":"1970","unstructured":"Grelak, R. P., Clark, R., Stump, J. M., Vernier, V. G.: Amantadine-dopamine interaction: possible mode of action in Parkinsonism. Science 169, 203?204 (1970).","journal-title":"Science"},{"key":"CR13","first-page":"12","volume":"12","author":"T. J. Hayle","year":"1957","unstructured":"Hayle, T. J., McCormick, W. G.: Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Brit. J. Pharmacol. 12, 12?15 (1957).","journal-title":"Brit. J. Pharmacol."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/0006-2952(68)90103-2","volume":"17","author":"P. V. Halushka","year":"1968","unstructured":"Halushka, P. V., Hoffmann, P. C.: Does tetrahydropapaveroline contribute to the cardiovascular actions of dopamine? Biochem. Pharmacol. 17, 1873?1880 (1968).","journal-title":"Biochem. Pharmacol."},{"key":"CR15","first-page":"129","volume":"134","author":"S. M. Hess","year":"1961","unstructured":"Hess, S. M., Connamacher, R. H., Ozaki, M., Udenfriend, S.: The effects of ?-methyl-DOPA and ?-methylmetatyrosine on the metabolism of norepinephrine and serotonin in vivo. J. Pharmacol. exp. Ther. 134, 129?138 (1961).","journal-title":"J. Pharmacol. exp. Ther."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/203656b0","volume":"203","author":"P. Holtz","year":"1964","unstructured":"Holtz, P., Stock, K., Westermann, E.: Formation of tetrahydropapaveroline from dopamine in vitro. Nature (Lond.) 203, 656?658 (1964).","journal-title":"Nature (Lond.)"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0013-4694(68)90158-2","volume":"25","author":"W. R. Koella","year":"1968","unstructured":"Koella, W. R., Feldstein, A., Czicman, J. S.: The effects of para-chlorophenylalanine on the sleep of cats. Electroenceph. clin. Neurophysiol. 25, 481?490 (1968).","journal-title":"Electroenceph. clin. Neurophysiol."},{"key":"CR18","first-page":"72","volume":"47","author":"A. Loizzo","year":"1969","unstructured":"Loizzo, A.: Correlati elettroencefalografici dell'azione di alcuni farmaci psicotropi sul topo (Mus Musculus L.) libero non anestetizzato. II. EEG e comportamento nel topo trattato con farmaci anticolinergici. Studi sassaresi 47, (suppl.) 72?91 (1969).","journal-title":"Studi sassaresi"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0013-4694(60)90114-0","volume":"12","author":"V. G. Longo","year":"1960","unstructured":"Longo, V. G.: Action de la chlorpromazine, de la l\u00e9vomepromazine et de la prochlorp\u00e9mazine sur l'activit\u00e9 \u00e9lectrique c\u00e9r\u00e9brale et sur le comportement du lapin. Electroenceph. clin. Neurophysiol. 12, 693?704 (1960).","journal-title":"Electroenceph. clin. Neurophysiol."},{"key":"CR20","first-page":"676","volume":"70","author":"V. G. Longo","year":"1970","unstructured":"?, Florio, V.: Effects of neuroleptic drugs on the cerebral electrical activity of laboratory animals. Presentation of a model design for neuropharmacological experiments. Acta psychiat. belg. 70, 676?687 (1970).","journal-title":"Acta psychiat. belg."},{"key":"CR21","first-page":"84","volume":"137","author":"C. Morpurgo","year":"1962","unstructured":"Morpurgo, C.: Effects of antiparkinson drugs on a phenothiazine-induced catatonic reaction. Arch. int. Pharmacodyn. 137, 84?90 (1962).","journal-title":"Arch. int. Pharmacodyn."},{"key":"CR22","first-page":"2185 to 2187","volume":"149","author":"P. Passouant","year":"1955","unstructured":"Passouant, P., Passouant-Fontaine, Th., Cadilhac, J.: Modifications de l'excitabilit\u00e9 du cortex et de diverses structures sous-corticales au cours de la catalepsie provoqu\u00e9e par la bulbocapnine chez le chat. C. R. Biol. Soc. (Paris) 149, 2185 to 2187 (1955).","journal-title":"C. R. Biol. Soc. (Paris)"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.2042-7158.1971.tb08628.x","volume":"23","author":"K. J. Rogers","year":"1971","unstructured":"Rogers, K. J., Slater, P.: Brain acetylcholine and monoamines during experimental catatonia. J. Pharm. Pharmacol. 23, 135?137 (1971).","journal-title":"J. Pharm. Pharmacol."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(70)90194-9","volume":"13","author":"B. Scatton","year":"1970","unstructured":"Scatton, B., Cheramy, A., Besson, M. J., Glowinsky, J.: Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment. Europ. J. Pharmacol. 13, 131?133 (1970).","journal-title":"Europ. J. Pharmacol."},{"key":"CR25","first-page":"625","volume-title":"Psychopharmacology","author":"J. J. Schildkraut","year":"1968","unstructured":"Schildkraut, J. J., Davis, J. M., Klerman, G. L.: Biochemistry of depressions. In: Psychopharmacology, pp. 625?648. D. H. Efron, ed. Washington: Public Health Service Publication 1968."},{"key":"CR26","first-page":"939","volume":"25","author":"P. Simon","year":"1970","unstructured":"Simon, P., Chermat, R., Larousse, C., Boissier, J. R.: Action de la bulbocapnine sur quelques tests de psychopharmacologie. Th\u00e9rapie 25, 939?949 (1970).","journal-title":"Th\u00e9rapie"},{"key":"CR27","first-page":"985","volume":"24","author":"P. Simon","year":"1969","unstructured":"?, Langwinski, R., Boissier, J. R.: Comparaison de diff\u00e9rents tests d'\u00e9valuation de la catalepsie chez le rat. Th\u00e9rapie 24, 985?995 (1969).","journal-title":"Th\u00e9rapie"},{"key":"CR28","first-page":"86","volume":"147","author":"S. Spector","year":"1965","unstructured":"Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade od endogenous norepinephrine synthesis by ?-methyltyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 147, 86?95 (1965).","journal-title":"J. Pharmacol. exp. Ther."},{"key":"CR29","first-page":"255","volume":"16","author":"G. Stille","year":"1966","unstructured":"Stille, G.: Arousalhemmung und Katalepsie bei Neuroleptica. Arzneimittel-Forsch. 16, 255?256 (1966).","journal-title":"Arzneimittel-Forsch."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/BF02136429","volume":"23","author":"G. Stille","year":"1967","unstructured":"?, Sayers, A.: Concerning the effect of bulbocapnine on the caudate loop. Experientia (Basel) 23, 1028?1029 (1967).","journal-title":"Experientia (Basel)"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1749-6632.1962.tb50122.x","volume":"96","author":"F. Sulser","year":"1962","unstructured":"Sulser, F., Watts, J., Brodie, B. B.: On the mechanism of antidepressant action of imipramine like drugs. Ann. N. Y. Acad. Sci. 96, 279?288 (1962).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0013-4694(54)90023-1","volume":"6","author":"E. G. Szekely","year":"1954","unstructured":"Szekely, E. G., Spiegel, E. A.: The effect of bulbocapnine upon the spontaneous electric activity of the brain and its reactivity to afferent stimuli. Electroenceph. clin. Neurophysiol. 6, 213?219 (1954).","journal-title":"Electroenceph. clin. Neurophysiol."},{"key":"CR33","first-page":"198","volume":"12","author":"L. F. Tseng","year":"1970","unstructured":"Tseng, L. F., Walaszek, E. J.: Influence of alteration of catecholamine and serotonin levels on bulbocapnine-induced catatonia. Pharmacologist 12, 198 (1970).","journal-title":"Pharmacologist"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1749-6632.1962.tb50119.x","volume":"96","author":"J. A. Waada","year":"1962","unstructured":"Waada, J. A.: Behavioral and electrographic effects of intraventricular injection of bulbocapnine and other substances in freely moving monkeys. Ann. N. Y. Acad. Sci. 96, 227?250 (1962).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"CR35","first-page":"388","volume":"174","author":"M. J. Walsh","year":"1970","unstructured":"Walsh, M. J., Davies, V. E., Yamanaka, Y.: Tetrahydropapaveroline: an alkaloid metabolite of dopamine in vitro. J. Pharmac. exp. Ther. 174, 388?400 (1970).","journal-title":"J. Pharmac. exp. Ther."},{"key":"CR36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF00997288","volume":"266","author":"G. Zetler","year":"1970","unstructured":"Zetler, G.: Anticataleptic actions of amantadine hydrochloride. Naunyn-Schmiedebergs Arch. Pharmak. 266, 276?278 (1970).","journal-title":"Naunyn-Schmiedebergs Arch. Pharmak."},{"key":"CR37","first-page":"486","volume":"238","author":"G. Zetler","year":"1960","unstructured":"?, Mahler, K., Daniel, F.: Versuche zu einer pharmakologischen Differenzierung kataleptischer Wirkungen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 238, 486?501 (1960).","journal-title":"Naunyn-Schmiedebergs Arch. exp. Path. Pharmak."},{"key":"CR38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/BF00246361","volume":"232","author":"G. Zetler","year":"1958","unstructured":"?, Moog, E.: Die Bulbocapnine-Katatonie, ihre Synergisten und Antagonisten. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 232, 442?458 (1958).","journal-title":"Naunyn-Schmiedebergs Arch. exp. Path. Pharmak."}],"container-title":["Psychopharmacologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00401786.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00401786\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00401786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T22:17:58Z","timestamp":1554329878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00401786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1971,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1971,9]]}},"alternative-id":["BF00401786"],"URL":"https:\/\/doi.org\/10.1007\/bf00401786","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1971,9]]}}}